Status | Study |
Completed |
Study Name: Evaluation of Non Specific Symptoms and Quality of Life Before and After Surgery for Mild Primary Hyperparathyroidism Condition: Primary Hyperparathyroidism Date: 2012-10-24 |
Completed |
Study Name: Denosumab in Primary Hyperparathyroidism Condition: Primary Hyperparathyroidism Date: 2012-03-16 Interventions: Drug: Denosumab |
Completed |
Study Name: Surgical Approach for Primary Hyperparathyroidism in the Elderly Condition: Multigland Disease in Primary Hyperparathyroidism Date: 2011-12-01 Interventions: Procedure: unilateral neck exploration All elderly patients with primary hyperparathyroidism suspected t |
Completed |
Study Name: A Prospective Cohort Study to Describe the Evolution of Persistent Hyperparathyroidism in Kidney Transplant Recipients Condition: Hyperparathyroidism Date: 2010-07-14 |
Recruiting |
Study Name: Surgery for Primary Hyperparathyroidism (pHPT) in Patients Older Than 65 Years Compared With Follow-up Condition: Primary Hyperparathyroidism Date: 2010-03-15 Interventions: Procedure: Parathyroid surgery Parathyroid Surgery (regardless of surgical strategy; i.e., focused opera |
Completed |
Study Name: Effects of Parathyroidectomy on Cardiovascular Risk Factors in Primary Hyperparathyroidism Condition: Primary Hyperparathyroidism Date: 2010-01-25 |
Terminated |
Study Name: Lipids Profile in Primary Hyperparathyroidism Condition: Primary Hyperparathyroidism Date: 2009-08-18 |
Completed |
Study Name: A Multicenter, Open-label Extension Study to Assess the Long-term Safety and Efficacy of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism Condition: Hyperparathyroidism, Primary Date: 2009-06-04 Interventions: Drug: cinacalcet Subjects began open-label treatment with 30 mg cinacalcet twice daily (BID) at the star |
Completed |
Study Name: A Study to Assess the Efficacy and Safety of Twice-Daily Dose Regimens of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism (PHPT) Condition: Hyperparathyroidism, Primary Date: 2009-06-04 Interventions: Drug: placebo Subjects were ti |
Completed |
Study Name: Energy Specific Far Infrared Radiation Treatment for Hyperparathyroidism Condition: Hyperparathyroidism Date: 2007-12-12 Interventions: Radiation: Far Infrared Radiation Far Infrared Radiation (5μm to 20μm wavelength) for 30 to 40 |